Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-002447
Filing Date
2025-03-07
Accepted
2025-03-07 06:15:33
Documents
111
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tbph-20241231x10k.htm   iXBRL 10-K 2785548
2 EX-10.19 tbph-20241231xex10d19.htm EX-10.19 120531
3 EX-19 tbph-20241231xex19.htm EX-19 197215
4 EX-21.1 tbph-20241231xex21d1.htm EX-21.1 3007
5 EX-23.1 tbph-20241231xex23d1.htm EX-23.1 4448
6 EX-31.1 tbph-20241231xex31d1.htm EX-31.1 10383
7 EX-31.2 tbph-20241231xex31d2.htm EX-31.2 10191
8 EX-32 tbph-20241231xex32.htm EX-32 15313
9 GRAPHIC tbph-20241231x10k007.jpg GRAPHIC 29152
10 GRAPHIC tbph-20241231x10k008.jpg GRAPHIC 20034
11 GRAPHIC tbph-20241231x10k009.jpg GRAPHIC 3307
12 GRAPHIC tbph-20241231x10k010.jpg GRAPHIC 10473
  Complete submission text file 0001558370-25-002447.txt   12546598

Data Files

Seq Description Document Type Size
13 EX-101.SCH tbph-20241231.xsd EX-101.SCH 81269
14 EX-101.CAL tbph-20241231_cal.xml EX-101.CAL 75249
15 EX-101.DEF tbph-20241231_def.xml EX-101.DEF 329051
16 EX-101.LAB tbph-20241231_lab.xml EX-101.LAB 693189
17 EX-101.PRE tbph-20241231_pre.xml EX-101.PRE 537091
114 EXTRACTED XBRL INSTANCE DOCUMENT tbph-20241231x10k_htm.xml XML 2223521
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36033 | Film No.: 25717489
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)